LEPU MED.T.B. SP.GDR O.N.

Healthcare · EUR · F

07Z0

Price

€12.843

-0.10%

Cap

€2.34B

Earnings

—

30d Trend

-0.4%

07Z0

Loading chart data...

0 days · % change from startPowered by Brain47

VolatilityLow

12% annualised over 90 days

BRAIN47 SIGNAL

STRONG

Risk Level15

Quality64

Momentum48

Technical47

Fundamentals90

Raw weighted: 67×Macro 0.99 (−1%)=66

RISK

15/100

90d Volatility

12.4%Low

ATR %

0.3%Low daily moves

Max Drawdown (1Y)

-5.4%Resilient

QUALITY

64/100

ROE (avg)

4.9%Weak

Piotroski F-Score

6/9Average

Margin Stability

CV 2.6%Very stable

Accruals

-2.1%Cash earnings

Interest Coverage

8.7xAdequate

MOMENTUM

48/100

12-1M Momentum

-3.3%Downtrend

6-1M Momentum

-1.6%Flat

1M Return

-0.8%Stable

Relative Strength

-0.1% vs sectorIn-line

TECHNICAL

47/100

RSI (14)

42.4Neutral

Price vs SMA200

-1.5%Flat

MACD

-0.01Bearish momentum

Bollinger Band

14%Near lower band

SMA Cross

Golden CrossGolden Cross

Trend Quality (KER)

0.226Noisy/choppy

FUNDAMENTALS

90/100

P/FCF

2.7Cheap

P/S

0.4Cheap

Shareholder Yield

29.1%Strong returns

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months34

3-12 months42

1-5+ years ★75

Long-term compounder with 15.0% yield

BRAIN47'S ASSESSMENT

I rate LEPU MED.T.B. SP.GDR O.N. at 66/100 — a STRONG reading on the Brain47 Signal. The strongest factor is fundamentals at 90/100. I classify this as a income position with the strongest thesis on a long-term horizon.

PAST PERFORMANCE

1 MONTH

-0.8%

3 MONTHS

-0.8%

12 MONTHS

-4.1%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Long-term compounder with 15.0% yield. Fundamentals (90) and low-risk profile are the primary strengths. Historical volatility is low at 12%. I classify this as an income position — the 15.0% yield combined with low volatility makes it suitable for income generation.

incomeScore: 66/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.